260 related articles for article (PubMed ID: 27071591)
1. [Aldosterone antagonists--first choice in resistant hypertension].
Holzgreve H
MMW Fortschr Med; 2016 Apr; 158(7):65-6. PubMed ID: 27071591
[No Abstract] [Full Text] [Related]
2. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
Reincke M
MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension.
Pelliccia F; Rosano G; Patti G; Volterrani M; Greco C; Gaudio C
Int J Cardiol; 2015 Dec; 200():8-11. PubMed ID: 25466561
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
Sato A
Hypertens Res; 2013 Mar; 36(3):185-90. PubMed ID: 23171954
[TBL] [Abstract][Full Text] [Related]
5. ARAs to the RESCUE.
Kaplan NM
J Am Soc Hypertens; 2016 Mar; 10(3):187-8. PubMed ID: 27408946
[No Abstract] [Full Text] [Related]
6. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP
Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
[TBL] [Abstract][Full Text] [Related]
7. [Mineralocorticoid receptor antagonists: inhibition of the renin angiotensin system].
Derer W; Dechend R; Müller DN
MMW Fortschr Med; 2010 Feb; 152(6):48-9. PubMed ID: 20302183
[No Abstract] [Full Text] [Related]
8. Aldosterone antagonism: an emerging strategy for effective blood pressure lowering.
Pratt-Ubunama MN; Nishizaka MK; Calhoun DA
Curr Hypertens Rep; 2005 Jun; 7(3):186-92. PubMed ID: 15913492
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of aldosterone excess.
Deinum J; Riksen NP; Lenders JW
Pharmacol Ther; 2015 Oct; 154():120-33. PubMed ID: 26213109
[TBL] [Abstract][Full Text] [Related]
10. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
Riester A; Reincke M
Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
[TBL] [Abstract][Full Text] [Related]
11. Comparison of agents that affect aldosterone action.
Tamargo J; Solini A; Ruilope LM
Semin Nephrol; 2014 May; 34(3):285-306. PubMed ID: 25016400
[TBL] [Abstract][Full Text] [Related]
12. Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension.
Schneider A; Schwab J; Karg MV; Kalizki T; Reinold A; Schneider MP; Schmieder RE; Schmidt BM
J Hypertens; 2017 May; 35(5):1086-1092. PubMed ID: 28118280
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone and volume management in hypertensive heart disease.
Sica DA
Semin Nephrol; 2014 May; 34(3):323-32. PubMed ID: 25016402
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
15. Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist.
Sato A; Fukuda S
Hypertens Res; 2013 Oct; 36(10):879-84. PubMed ID: 23864056
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor antagonists and endothelial function.
Maron BA; Leopold JA
Curr Opin Investig Drugs; 2008 Sep; 9(9):963-9. PubMed ID: 18729003
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone in patients with heart failure.
Glick G
N Engl J Med; 2000 Jan; 342(2):133; author reply 133-4. PubMed ID: 10636752
[No Abstract] [Full Text] [Related]
18. Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics.
Epstein M; Calhoun DA
J Clin Hypertens (Greenwich); 2011 Sep; 13(9):644-8. PubMed ID: 21896143
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone: cardiovascular protection.
Brown NJ
Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
[TBL] [Abstract][Full Text] [Related]
20. Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues.
Kalidindi SR; Tang WH; Francis GS
Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):368-78. PubMed ID: 17589427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
